Skip to content

Modulation of Motor Cortex Excitability by TMS and tDCS (MAGS1)

Modulation of Motor Cortex Excitability by Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03481309
Enrollment
19
Registered
2018-03-29
Start date
2018-08-24
Completion date
2019-02-01
Last updated
2021-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor Activity, Motor Neuroplasticity

Keywords

transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), electroencephalography (EEG)

Brief summary

Investigating modulation of motor cortex excitability by transcranial magnetic stimulation and transcranial direct current stimulation.

Detailed description

Purpose of this pilot study is to modulate the motor cortex excitability by transcranial magnetic stimulation and transcranial direct current stimulation. Electromyography will be recorded on right abductor digiti minimi muscle to find the motor threshold and measure motor evoked potentials for each healthy participant. In addition, electroencephalography (EEG) data will be collected on the scalp with a high-density EEG net. Eighteen healthy participants will be in this study. Each participant will be seated in a reclining chair and applied non-invasive magnetic and electrical stimulations on the scalp. At baseline, the participant's resting motor threshold (RMT) will be estimated by adjusting the intensity of TMS applied on the left motor cortex to achieve motor-evoked potentials of about 50 uV with 10 TMS pulses at a rate of 0.25 Hz. Then a 3-condition, 3-session, 6-sequence randomized crossover experiment will be used to characterize and compare three versions of tDCS stimulation: anode, cathode, sham. Before and after a 10-min tDCS condition is applied, TMS pulses at 120% of RMT intensity will be applied for 10 minutes and TMS-evoked potential and motor-evoked potential amplitudes will be measured. Each session has at least 1-day gap to remove outlasting effects. We will also be collecting structural magnetic resonance imaging (sMRI) to target primary motor cortex precisely.

Interventions

DEVICEanodal tDCS

The participant will receive anodal tDCS with 2 mA for 10 minutes on the left motor cortex.

The participant will receive cathodal tDCS with -2 mA for 10 minutes on the left motor cortex.

DEVICEsham tDCS

The participant will receive sham tDCS with 2 mA for 40 seconds on the left motor cortex which mimics the skin sensations as active tDCS interventions.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

This is a double-blind and cross-over study.

Intervention model description

Each participant will be assigned to 2 active and sham conditions on a different day.

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * Between the ages of 18 and 35 * Right-handed * Capacity to understand all relevant risks and potential benefits of the study (informed consent) * Willing to comply with all study procedures and be available for the duration of the study * Speak and understand English

Exclusion criteria

* Prior concussion * Diagnosis of eating disorder (current or within the past 6 months) * Diagnosis of obsessive compulsive disorder (lifetime) * Attention-deficit/hyperactivity disorder (currently under treatment) * Neurological disorders and conditions, including, but not limited to: * History of epilepsy * Seizures (except childhood febrile seizures and electroconvulsive therapy-induced seizures) * Dementia * History of stroke * Parkinson's disease * Multiple sclerosis * Cerebral aneurysm * Brain tumors * Medical or neurological illness or treatment for a medical disorder that could interfere with study participation (e.g., unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment) * Prior brain surgery * Any brain devices/implants, including cochlear implants and aneurysm clips * Traumatic brain injury * Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study

Design outcomes

Primary

MeasureTime frameDescription
Changes in Motor-evoked Potentials Ratiosright before and after 2mA tDCS stimulation for 10 minutes at each sessionThe investigators will record motor-evoked potentials and calculate changes in between before and after 2mA tDCS stimulation for 10 minutes.
Changes in TMS-evoked Potentials Ratiosright before and after 2mA tDCS stimulation for 10 minutes at each sessionThe investigators will record TMS-evoked potentials using EEG and calculate changes in between before and after 2mA tDCS stimulation for 10 minutes.

Secondary

MeasureTime frameDescription
Changes in Resting-state EEG Dynamics Ratios4 minutes recordings before and after each 2mA tDCS stimulation for 10 minutes at each sessionThe investigators will record participants' resting state for 4 minutes using EEG (2 minutes for eyes-closed and 2 minutes for eyes-open)

Countries

United States

Participant flow

Participants by arm

ArmCount
Anode -> Cathode -> Sham
During 3 study visits, participants will receive anodal tDCS first, then cathodal tDCS, then sham tDCS. For all three tDCS conditions, two electrodes will be applied to the scalp (one on the left motor cortex, one on the right supraorbital cortex) for 10 minutes.
4
Anode -> Sham -> Cathode
During 3 study visits, participants will receive anodal tDCS first, then sham tDCS, then cathodal tDCS. For all three tDCS conditions, two electrodes will be applied to the scalp (one on the left motor cortex, one on the right supraorbital cortex) for 10 minutes.
3
Cathode -> Anode -> Sham
During 3 study visits, participants will receive cathodal tDCS first, then anodal tDCS, then sham tDCS. For all three tDCS conditions, two electrodes will be applied to the scalp (one on the left motor cortex, one on the right supraorbital cortex) for 10 minutes.
3
Cathode -> Sham -> Anode
During 3 study visits, participants will receive cathodal tDCS first, then sham tDCS, then anodal tDCS. For all three tDCS conditions, two electrodes will be applied to the scalp (one on the left motor cortex, one on the right supraorbital cortex) for 10 minutes.
3
Sham -> Anode -> Cathode
During 3 study visits, participants will receive sham tDCS first, then anodal tDCS, then cathodal tDCS. For all three tDCS conditions, two electrodes will be applied to the scalp (one on the left motor cortex, one on the right supraorbital cortex) for 10 minutes.
3
Sham -> Cathode -> Anode
During 3 study visits, participants will receive sham tDCS first, then cathodal tDCS, then anodal tDCS. For all three tDCS conditions, two electrodes will be applied to the scalp (one on the left motor cortex, one on the right supraorbital cortex) for 10 minutes.
3
Total19

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005
Washout (at Least 3 Days)Withdrawal by Subject100000

Baseline characteristics

CharacteristicAnode -> Sham -> CathodeCathode -> Anode -> ShamCathode -> Sham -> AnodeSham -> Anode -> CathodeSham -> Cathode -> AnodeAnode -> Cathode -> ShamTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
3 Participants3 Participants3 Participants3 Participants3 Participants4 Participants19 Participants
Age, Continuous25.33 years
STANDARD_DEVIATION 6.94
22.33 years
STANDARD_DEVIATION 1.24
20.66 years
STANDARD_DEVIATION 0.47
22 years
STANDARD_DEVIATION 4.24
25.33 years
STANDARD_DEVIATION 6.12
28.75 years
STANDARD_DEVIATION 6.68
24.31 years
STANDARD_DEVIATION 5.84
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants0 Participants1 Participants2 Participants0 Participants4 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants2 Participants1 Participants0 Participants1 Participants4 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants0 Participants0 Participants1 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
2 Participants1 Participants1 Participants1 Participants1 Participants2 Participants8 Participants
Region of Enrollment
United States
3 Participants3 Participants3 Participants3 Participants3 Participants4 Participants19 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Sex: Female, Male
Male
3 Participants3 Participants3 Participants3 Participants3 Participants4 Participants19 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 190 / 180 / 18
other
Total, other adverse events
0 / 190 / 180 / 18
serious
Total, serious adverse events
0 / 190 / 180 / 18

Outcome results

Primary

Changes in Motor-evoked Potentials Ratios

The investigators will record motor-evoked potentials and calculate changes in between before and after 2mA tDCS stimulation for 10 minutes.

Time frame: right before and after 2mA tDCS stimulation for 10 minutes at each session

Population: One participant signed the consent form but data for this participant was not recorded.

ArmMeasureValue (MEAN)Dispersion
Anodal tDCSChanges in Motor-evoked Potentials Ratios1.32 Ratio (unit: uV)Standard Error 0.09
Cathodal tDCSChanges in Motor-evoked Potentials Ratios0.73 Ratio (unit: uV)Standard Error 0.07
Sham tDCSChanges in Motor-evoked Potentials Ratios1.03 Ratio (unit: uV)Standard Error 0.05
Primary

Changes in TMS-evoked Potentials Ratios

The investigators will record TMS-evoked potentials using EEG and calculate changes in between before and after 2mA tDCS stimulation for 10 minutes.

Time frame: right before and after 2mA tDCS stimulation for 10 minutes at each session

Population: One participant signed the consent form but data for this participant was not recorded.

ArmMeasureValue (MEAN)Dispersion
Anodal tDCSChanges in TMS-evoked Potentials Ratios1.5 Ratio (unit: uV)Standard Deviation 0.5
Cathodal tDCSChanges in TMS-evoked Potentials Ratios0.8 Ratio (unit: uV)Standard Deviation 0.4
Sham tDCSChanges in TMS-evoked Potentials Ratios1.1 Ratio (unit: uV)Standard Deviation 0.4
Secondary

Changes in Resting-state EEG Dynamics Ratios

The investigators will record participants' resting state for 4 minutes using EEG (2 minutes for eyes-closed and 2 minutes for eyes-open)

Time frame: 4 minutes recordings before and after each 2mA tDCS stimulation for 10 minutes at each session

Population: One participant signed the consent form but data for this participant was not recorded.

ArmMeasureValue (MEAN)Dispersion
Anodal tDCSChanges in Resting-state EEG Dynamics Ratios1.2 Ratio (unit: uV)Standard Deviation 0.7
Cathodal tDCSChanges in Resting-state EEG Dynamics Ratios0.8 Ratio (unit: uV)Standard Deviation 0.3
Sham tDCSChanges in Resting-state EEG Dynamics Ratios1.1 Ratio (unit: uV)Standard Deviation 0.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026